Cambridge Cog News Headlines. COG Share News. Financial News Articles for Cambridge Cognition Holdings Plc Ord 1p updated throughout the day.

30 Jun 2020 20:26

IN BRIEF: Cambridge Cognition Interim Order Intake Surges Annually

30 Jun 2020 11:00

Cambridge Cognition order intake nearly doubles in H1

(Sharecast News) - Software group Cambridge Cognition has seen its order intake almost double in the six months ended 30 June following the company's switch in focus to having a more diversified portfolio and its efforts to commercialise new products.

27 May 2020 13:10

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

27 May 2020 10:08

Cambridge Cognition inks multiple new contracts for virtual trials

(Sharecast News) - Digital brain health products developer Cambridge Cognition has secured several new contracts to support pharmaceutical clients in delivering virtual clinical trials, including two contracts collectively worth over £1m.

5 May 2020 12:11

Cambridge Cognition 2019 Loss Widens As Revenue Falls On Sales Decline

17 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

17 Mar 2020 16:02

Cambridge Cognition Three Contracts Worth Total Of GBP1.4 Million

2 Mar 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

19 Feb 2020 09:40

Cambridge Cognition To Raise GBP1.4 Million; Expects Wider Annual Loss

19 Feb 2020 08:03

Cambridge Cognition losses widen amid sales slump

(Sharecast News) - Digital solutions development group Cambridge Cognition warned on Wednesday that its full-year losses were set to widen after the lower level of sales seen throughout the first half of the year extended into the third quarter

25 Nov 2019 09:36

Cambridge Cognition gains client with improved electronic assessment platform

(Sharecast News) - Brain health solutions developer Cambridge Cognition Holdings announced the launch of an improved electronic clinical outcomes assessment ('eCOA') platform on Monday, claiming it had already attracted a new client from one of the world's top 10 pharmaceutical companies.

25 Oct 2019 15:22

Cambridge Cognition hoping to ride coat-tails of Biogen Alzheimer's programme

(Sharecast News) - Cambridge Cognition announced on Friday that, Following a consultation with the US Food and Drug Administration (FDA), Biogen and Eisai have announced plans to pursue regulatory approval for 'aducanumab', which would be the first therapy to tackle clinical decline in early Alzheimer's disease.

25 Oct 2019 10:37